Security Snapshot

GILEAD SCIENCES, INC. - Common Stock (GILD) Institutional Ownership

CUSIP: 375558103

13F Institutional Holders and Ownership History from Q1 2014 to Q3 2026

13F reference period

Q3 2026

Institutions Reporting

1,802

Shares (Excl. Options)

569.06MFull value: 569,057,468 · shares · 30 Sep 2026

Price

$149.05

The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Create free account and return here Sign in and return here Review latest holder period
Security type / class
Equity / Common Stock
Symbol
GILD on Nasdaq
All holders as of 30 Sep 2026
Q3 2026
Total 13F shares
569,057,468
Latest holder snapshot 5 signals
Total 13F value
$84,922,712,312
Portfolio coverage rank
0.05%
Share change
+34,433
Value change
+$79,806,773
Number of holders
1,802
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
1,242,704,754
SEC-reported price per share
$147.10
Insider filing price
$147.10
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • GILD - GILEAD SCIENCES, INC. - Common Stock is tracked under CUSIP 375558103.
  • 1802 institutions reported positions in Q3 2026.
  • 4 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 2,290 to 1,802 between Q2 2026 and Q3 2026.
  • SEC-reported value moved from
    $140.52BFull value: $140,518,195,598 · USD · 30 Jun 2026
    to
    $84.92BFull value: $84,922,712,312 · USD · 30 Sep 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 1802 institutions filings for Q3 2026.

Open SEC evidence

Security key

375558103

13F reference period

Q3 2026

13F holders

1,802

13D/G owners

4

CIK / CUSIP context first

Open Q3 2026 holders GILD full holder history GILEAD SCIENCES, INC. SEC filings GILEAD SCIENCES, INC. company facts GILEAD SCIENCES, INC. insider transactions GILEAD SCIENCES, INC. 13D/G history

Broader feeds

Latest 13F filings Latest 13D/G filings All securities

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
4
Security
GILD
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 8.2% $10,799,623,829 101,739,273 BlackRock, Inc. 31 Mar 2025
VANGUARD CAPITAL MANAGEMENT LLC 7.5% $13,007,001,690 93,327,127 Vanguard Capital Management 31 Mar 2026
FMR LLC 5.3% $8,044,315,376 65,539,477 FMR LLC 31 Dec 2025
Capital World Investors 4.3% $5,714,571,769 53,834,873 Capital World Investors 31 Mar 2025
As of 30 Sep 2026, 1,802 institutional investors reported holding
569.06MFull value: 569,057,468 · shares · 30 Sep 2026
shares of GILEAD SCIENCES, INC. - Common Stock (GILD). This represents 46% of the company’s total
1.24BFull value: 1,242,704,754 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
35%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD CAPITAL MANAGEMENT LLC 6.5% 81,175,627 +0.1% 0.25% $12,099,227,204
STATE STREET CORP 4.9% 60,954,967 -0.43% 0.26% $9,085,337,831
Invesco Ltd. 3.1% 38,662,436 -2.9% 0.45% $5,762,636,028
Capital World Investors 2.9% 35,929,833 -12% 0.65% $5,355,872,692
VANGUARD PORTFOLIO MANAGEMENT LLC 2.9% 35,685,818 +1% 0.24% $5,318,971,173
GEODE CAPITAL MANAGEMENT, LLC 2.4% 30,190,640 +0.42% 0.23% $4,485,711,723
Capital Research Global Investors 1.9% 23,980,766 +24% 0.51% $3,574,341,919
MORGAN STANLEY 1.9% 23,755,334 -1% 0.18% $3,540,733,033
Dodge & Cox 1.8% 21,800,593 -7.9% 1.7% $3,249,378,387
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 0.92% 11,461,347 +76% 0.64% $1,765,949,503
Amundi 0.91% 11,259,657 +15% 0.37% $1,678,251,875
DEUTSCHE BANK AG\ 0.77% 9,613,980 +32% 0.4% $1,432,963,720
DIMENSIONAL FUND ADVISORS LP 0.63% 7,799,464 -1.3% 0.21% $1,162,634,058
VANGUARD FIDUCIARY TRUST CO 0.56% 7,000,294 +0.41% 0.23% $1,043,393,821
NORDEA INVESTMENT MANAGEMENT AB 0.43% 5,334,829 +3.5% 0.63% $802,384,956
FRANKLIN TEMPLETON INC 0.29% 3,590,890 +2.9% 0.13% $626,561,568
Robeco Institutional Asset Management B.V. 0.28% 3,442,819 -0.49% 0.62% $513,152,173
Swiss National Bank 0.27% 3,395,900 -3% 0.27% $506,158,895
Mitsubishi UFJ Asset Management Co., Ltd. 0.27% 3,346,451 +6% 0.26% $498,788,522
National Pension Service 0.25% 3,081,344 +0.62% 0.29% $459,274,323
FIRST TRUST ADVISORS LP 0.25% 3,065,019 +2.5% 0.27% $456,841,090
VANGUARD ASSET MANAGEMENT, Ltd 0.24% 3,023,731 +7.3% 0.28% $450,687,106
AMERICAN CENTURY COMPANIES INC 0.24% 3,008,109 -24% 0.2% $448,358,847
Sumitomo Mitsui Trust Group, Inc. 0.24% 2,972,668 +0.34% 0.25% $443,076,165
Swedbank AB 0.23% 2,875,154 +51% 0.36% $428,541,704

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
51
Headline period
Q3 2026
Rows shown
1-25 of 51
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 569,057,468 $84,922,712,312 +$79,806,773 $149.05 1,802
2026 Q2 1,111,596,087 $140,518,195,598 +$4,334,042,551 $126.34 2,290
2026 Q1 1,074,089,765 $149,446,911,709 -$4,680,556,589 $139.37 2,331
2025 Q4 1,091,178,284 $133,784,770,682 +$3,510,541,306 $122.74 2,209
2025 Q3 1,055,277,570 $117,154,382,055 -$2,197,543,603 $111.00 2,009
2025 Q2 1,073,254,023 $118,963,159,666 +$3,514,130,825 $110.87 2,000
2025 Q1 1,043,338,274 $116,881,227,875 -$1,852,497,281 $112.05 1,991
2024 Q4 1,061,928,121 $98,045,307,663 +$1,597,585,192 $92.37 1,868
2024 Q3 1,041,031,806 $87,292,159,028 +$497,071,935 $83.84 1,702
2024 Q2 1,032,141,981 $70,791,566,038 -$264,255,142 $68.61 1,666
2024 Q1 1,039,326,218 $76,098,429,205 -$499,202,917 $73.25 1,705
2023 Q4 1,044,478,354 $84,656,377,441 +$255,439,953 $81.01 1,763
2023 Q3 1,039,821,240 $77,974,757,522 -$75,610,588 $74.94 1,671
2023 Q2 1,042,887,174 $80,416,194,253 +$427,085,098 $77.07 1,687
2023 Q1 1,034,794,880 $85,819,040,826 +$628,903,617 $82.97 1,717
2022 Q4 1,031,461,660 $88,551,084,722 +$2,216,871,534 $85.85 1,747
2022 Q3 1,003,983,340 $61,982,373,182 +$689,958,176 $61.69 1,570
2022 Q2 993,379,548 $61,392,230,451 +$324,575,776 $61.81 1,587
2022 Q1 988,770,035 $58,777,059,567 -$957,879,872 $59.45 1,567
2021 Q4 1,009,356,244 $73,295,492,986 +$193,423,902 $72.61 1,663
2021 Q3 999,239,167 $69,763,198,043 +$691,955,339 $69.85 1,544
2021 Q2 989,284,689 $68,064,289,407 +$647,772,893 $68.86 1,524
2021 Q1 981,962,949 $63,398,921,279 +$771,179,759 $64.63 1,551
2020 Q4 971,052,591 $56,534,223,402 -$194,225,396 $58.26 1,543
2020 Q3 975,382,123 $61,581,778,990 -$1,221,202,886 $63.19 1,524
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .